More info on drug review timelines? HHS and FDA pull Trump HHS’ last-minute pledge
HHS and FDA on Friday said they’re withdrawing a notice published just days before former President Donald Trump left office, which would’ve required the FDA to publish redundant information on the timelines for reviewing drug applications.
In addition to the FDA being entirely left out of the decision to publish the initial notice, the decision to pull the notice came as HHS and FDA said it did not account for what’s already publicly available about FDA’s review of drug applications.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.